Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$134M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Tarriff Scott | Nov 2, 2023 | Sell | 10,694 | $13.87 | $150,000 |
| Tarriff Scott | Nov 1, 2023 | Sell | 10,925 | $13.82 | $150,000 |
| Tarriff Scott | Oct 3, 2023 | Sell | 10,024 | $14.41 | $140,000 |
| Tarriff Scott | Oct 3, 2023 | Sell | 710 | $15.11 | $11,000 |
| Tarriff Scott | Oct 2, 2023 | Sell | 9,511 | $15.23 | $140,000 |
| Tarriff Scott | May 16, 2023 | Sell | 15,000 | $19.98 | $300,000 |
| Tarriff Scott | May 15, 2023 | Sell | 14,800 | $21.06 | $310,000 |
| Tarriff Scott | May 15, 2023 | Sell | 200 | $21.52 | $4,300 |
| Tarriff Scott | May 12, 2023 | Sell | 11,869 | $20.42 | $240,000 |
| Tarriff Scott | May 12, 2023 | Sell | 3,131 | $19.69 | $62,000 |
| Tarriff Scott | May 11, 2023 | Sell | 15,000 | $20.71 | $310,000 |
What's the latest insider transaction for Eagle Pharmaceuticals?
The most recent insider transaction for Eagle Pharmaceuticals was conducted by Tarriff Scott, who sold 10,694 shares on November 2, 2023 at a price of $13.87 per share.
Which insider has sold the most EGRX stock over the last two years?
Tarriff Scott has sold the most EGRX stock in the last 2 years, with a total value of $1.8M.
What is the total value of insider transactions for Eagle Pharmaceuticals (EGRX) in the last 2 years?
The total value of insider transactions for Eagle Pharmaceuticals in the last 2 years is negative, amounting to -$1.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Eagle Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Eagle Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
